Conventional T1/T2-weighted MRI has become indispensable for Multiple Sclerosis(MS) diagnosis and treatment monitoring, although it reflects only general macroscopic tissue damage. MRSI allows the additional mapping of pathological processes in MS on a biochemical level. In 39 relapsing-remitting MS patients and an age/sex-matched control group(n=10), we show that clinically feasible ultra-high resolution (100x100 matrix) FID-MRSI in ~6min reveals even well-delineated (sub-)cortical MS lesions down to ~3mm in regions inconspicuous on conventional MRI. Regions of mIns were often larger than on FLAIR and NAA maps, suggesting that mIns increase may be an earlier imaging biomarker for neuroinflammation/lesion development than conventional MRI.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords